Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas H Marx

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Human Pathology|July 27, 2010
Heterogenous high-level HER-2 amplification in a small subset of colorectal cancersAndreas H Marx, Eike C Burandt, Matthias Choschzick, et al.
Haematologica|May 25, 2011
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myelomaDjordje Atanackovic, Jens Panse, York Hildebrandt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lungTobias J Grob, Ivonne Kannengiesser, Maria C Tsourlakis, et al.
Pathology, Research and Practice|June 25, 2021
MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancerSebastian Dwertmann Rico, Barbara Schmalfeldt, Volkmar Müller, et al.
Cancer Investigation|June 18, 2021
Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer AggressivenessSören Weidemann, Daniel Perez, Jakob R Izbicki, et al.
Journal of the National Cancer Institute|June 30, 2012
Role of interleukin 16 in multiple myelomaDjordje Atanackovic, York Hildebrandt, Julia Templin, et al.
Histopathology|September 16, 2010
Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosisAndreas H Marx, Margarete Zielinski, Charlotte-Marie Kowitz, et al.
Biomedicines|May 25, 2024
Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 TumorsFlorian Viehweger, Jennifer Hoop, Lisa-Marie Tinger, et al.
Virchows Archiv : an International Journal of Pathology|August 6, 2024
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entitiesNatalia Gorbokon, Sarah Baltruschat, Maximilian Lennartz, et al.
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Human Pathology|July 27, 2010
Heterogenous high-level HER-2 amplification in a small subset of colorectal cancersAndreas H Marx, Eike C Burandt, Matthias Choschzick, et al.
Haematologica|May 25, 2011
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myelomaDjordje Atanackovic, Jens Panse, York Hildebrandt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lungTobias J Grob, Ivonne Kannengiesser, Maria C Tsourlakis, et al.
Pathology, Research and Practice|June 25, 2021
MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancerSebastian Dwertmann Rico, Barbara Schmalfeldt, Volkmar Müller, et al.
Cancer Investigation|June 18, 2021
Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer AggressivenessSören Weidemann, Daniel Perez, Jakob R Izbicki, et al.
Journal of the National Cancer Institute|June 30, 2012
Role of interleukin 16 in multiple myelomaDjordje Atanackovic, York Hildebrandt, Julia Templin, et al.
Histopathology|September 16, 2010
Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosisAndreas H Marx, Margarete Zielinski, Charlotte-Marie Kowitz, et al.
Biomedicines|May 25, 2024
Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 TumorsFlorian Viehweger, Jennifer Hoop, Lisa-Marie Tinger, et al.
Virchows Archiv : an International Journal of Pathology|August 6, 2024
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entitiesNatalia Gorbokon, Sarah Baltruschat, Maximilian Lennartz, et al.
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Pageof 11